Home Amira Pharmaceuticals

Amira Pharmaceuticals

acquired
Series B
Small Molecule Drug Developer

Basic Information

Amira Pharmaceuticals is a small-molecule pharmaceutical company focused on the discovery and early development of novel drugs for the treatment of inflammatory diseases. Their discovery team is built on an understanding of bioactive lipid pathways and the control of many diseases, including asthma, chronic obstructive pulmonary disease (COPD), cardiovascular diseases, and fibrotic conditions.
Amira Pharmaceuticals, Inc.
SanDiego,California,United States of America
15~50 people
February 01, 2005
--
info@amirapharm.com